The Food and Drug Administration (FDA) has given fast-track approval to Crizotinib in the fight against lung cancer. In this podcast, Dr. Renato Martins from the Seattle Cancer Care Alliance (SCCA,) explains what this new drug means for some people living with non-small cell lung cancer.
|
Renato Martins, M.D., M.P.H.
Medical Oncologist, Associate Professor of Medicine, Seattle Cancer Care Alliance, UW Medicine
Dr. Martins is a medical oncologist and associate professor of medicine, as well as medical director of the Thoracic/Head & Neck Cancer Program at the University of Washington. He is also medical director of Outpatient Services at the Seattle Cancer Care Alliance. He received his medical degree from Federal University of Rio de Janeiro in his home country of Brazil,...
more >
|
|
|

